CD133/AC133+ cells from SV40-immortalized prostate cells were observed to be incapable of generating tumors when recombined with UGSM cells or cancer-associated fibroblasts in immunocompromised mice, whereas CD133/AC133− cells formed xenograft tumors [46]. The gene discussed is PROM1; the disease is cancer.